By replacing refined wheat flour in a HFFD with the γ-oryzanol/phytosterol/ferulic acid-enriched flour, the lipid/glucose metabolic disorder in rats are significantly improved, as evidenced by an improved lipid profile, hepatic steatosis, glucose/insulin tolerance, insulin resistance, oxidative stress, hepatic function and hyperuricemia. This evidence concerns the gene INS and fatty liver disease.